DaLian2ndHosp |
FuJianUnionHosp |
PKU1stHosp |
Overall |
|||||
|---|---|---|---|---|---|---|---|---|
| Negative (N=15) |
Positive (N=48) |
Negative (N=22) |
Positive (N=63) |
Negative (N=263) |
Positive (N=69) |
Negative (N=300) |
Positive (N=180) |
|
| FinalDiagnosis | ||||||||
| Negative | 15 (100%) | 0 (0%) | 22 (100%) | 0 (0%) | 263 (100%) | 0 (0%) | 300 (100%) | 0 (0%) |
| Positive | 0 (0%) | 48 (100%) | 0 (0%) | 63 (100%) | 0 (0%) | 69 (100%) | 0 (0%) | 180 (100%) |
| Age | ||||||||
| Mean (SD) | 67.9 (7.18) | 71.1 (8.31) | 68.3 (7.33) | 69.7 (7.39) | 64.4 (11.1) | 69.7 (9.48) | 64.8 (10.7) | 70.1 (8.46) |
| Median [Min, Max] | 68.0 [58.0, 84.0] | 72.0 [53.0, 86.0] | 68.0 [54.0, 83.0] | 69.0 [50.0, 88.0] | 65.0 [29.0, 94.0] | 70.0 [53.0, 88.0] | 65.0 [29.0, 94.0] | 70.0 [50.0, 88.0] |
| tPSAValue | ||||||||
| Mean (SD) | 11.7 (7.56) | 22.4 (20.0) | 10.8 (9.46) | 40.4 (35.4) | 7.67 (5.35) | 6.51 (2.36) | 8.11 (5.95) | 22.6 (27.4) |
| Median [Min, Max] | 10.1 [4.84, 35.0] | 16.0 [5.31, 100] | 7.69 [1.46, 34.9] | 23.5 [1.61, 100] | 6.54 [0.150, 43.0] | 6.21 [0.849, 13.4] | 6.76 [0.150, 43.0] | 10.7 [0.849, 100] |
| GleasonScorePrimary | ||||||||
| 3 | 1 (6.7%) | 21 (43.8%) | 3 (13.6%) | 27 (42.9%) | 0 (0%) | 36 (52.2%) | 4 (1.3%) | 84 (46.7%) |
| 4 | 0 (0%) | 24 (50.0%) | 0 (0%) | 27 (42.9%) | 0 (0%) | 15 (21.7%) | 0 (0%) | 66 (36.7%) |
| 5 | 0 (0%) | 3 (6.3%) | 0 (0%) | 7 (11.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 10 (5.6%) |
| NoCancer | 14 (93.3%) | 0 (0%) | 19 (86.4%) | 0 (0%) | 263 (100%) | 0 (0%) | 296 (98.7%) | 0 (0%) |
| Missing | 0 (0%) | 0 (0%) | 0 (0%) | 2 (3.2%) | 0 (0%) | 18 (26.1%) | 0 (0%) | 20 (11.1%) |
| GleasonScoreSecondary | ||||||||
| 2 | 0 (0%) | 0 (0%) | 0 (0%) | 1 (1.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (0.6%) |
| 3 | 1 (6.7%) | 18 (37.5%) | 3 (13.6%) | 22 (34.9%) | 0 (0%) | 10 (14.5%) | 4 (1.3%) | 50 (27.8%) |
| 4 | 0 (0%) | 22 (45.8%) | 0 (0%) | 19 (30.2%) | 0 (0%) | 37 (53.6%) | 0 (0%) | 78 (43.3%) |
| 5 | 0 (0%) | 8 (16.7%) | 0 (0%) | 19 (30.2%) | 0 (0%) | 4 (5.8%) | 0 (0%) | 31 (17.2%) |
| NoCancer | 14 (93.3%) | 0 (0%) | 19 (86.4%) | 0 (0%) | 263 (100%) | 0 (0%) | 296 (98.7%) | 0 (0%) |
| Missing | 0 (0%) | 0 (0%) | 0 (0%) | 2 (3.2%) | 0 (0%) | 18 (26.1%) | 0 (0%) | 20 (11.1%) |
| GleasonScoreTotal | ||||||||
| 10 | 0 (0%) | 0 (0%) | 0 (0%) | 3 (4.8%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (1.7%) |
| 5 | 0 (0%) | 0 (0%) | 0 (0%) | 1 (1.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (0.6%) |
| 6 | 1 (6.7%) | 5 (10.4%) | 3 (13.6%) | 11 (17.5%) | 0 (0%) | 0 (0%) | 4 (1.3%) | 16 (8.9%) |
| 7 | 0 (0%) | 26 (54.2%) | 0 (0%) | 19 (30.2%) | 0 (0%) | 44 (63.8%) | 0 (0%) | 89 (49.4%) |
| 8 | 0 (0%) | 9 (18.8%) | 0 (0%) | 14 (22.2%) | 0 (0%) | 5 (7.2%) | 0 (0%) | 28 (15.6%) |
| 9 | 0 (0%) | 8 (16.7%) | 0 (0%) | 13 (20.6%) | 0 (0%) | 2 (2.9%) | 0 (0%) | 23 (12.8%) |
| NoCancer | 14 (93.3%) | 0 (0%) | 19 (86.4%) | 0 (0%) | 263 (100%) | 0 (0%) | 296 (98.7%) | 0 (0%) |
| Missing | 0 (0%) | 0 (0%) | 0 (0%) | 2 (3.2%) | 0 (0%) | 18 (26.1%) | 0 (0%) | 20 (11.1%) |
| ISUPGroup | ||||||||
| 1 | 1 (6.7%) | 5 (10.4%) | 3 (13.6%) | 12 (19.0%) | 0 (0%) | 0 (0%) | 4 (1.3%) | 17 (9.4%) |
| 2 | 0 (0%) | 13 (27.1%) | 0 (0%) | 10 (15.9%) | 0 (0%) | 34 (49.3%) | 0 (0%) | 57 (31.7%) |
| 3 | 0 (0%) | 13 (27.1%) | 0 (0%) | 9 (14.3%) | 0 (0%) | 10 (14.5%) | 0 (0%) | 32 (17.8%) |
| 4 | 0 (0%) | 9 (18.8%) | 0 (0%) | 14 (22.2%) | 0 (0%) | 5 (7.2%) | 0 (0%) | 28 (15.6%) |
| 5 | 0 (0%) | 8 (16.7%) | 0 (0%) | 16 (25.4%) | 0 (0%) | 2 (2.9%) | 0 (0%) | 26 (14.4%) |
| NoCancer | 14 (93.3%) | 0 (0%) | 19 (86.4%) | 0 (0%) | 263 (100%) | 0 (0%) | 296 (98.7%) | 0 (0%) |
| Missing | 0 (0%) | 0 (0%) | 0 (0%) | 2 (3.2%) | 0 (0%) | 18 (26.1%) | 0 (0%) | 20 (11.1%) |